Skip to main content

Table 2 Multiple logistic regression analyses for independent risk factors of NOAF

From: Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction

  Estimated β OR (95% CI) P value
Model 1    
 Age, years 0.12 1.127 (1.063–1.196) P < 0.001
 Hs-CRP, mg/L 0.034 1.034 (1.018–1.05) P < 0.001
 BNP, pg/ml 0.001 1 (0.999–1.001) 0.446
Model 2    
 Age, years 0.118 1.125 (1.036–1.221) 0.005
 Hs-CRP, mg/L 0.026 1.026 (1.01–1.048) 0.013
 LAD, mm 0.055 1.057 (0.921–1.213) 0.43
 LVEF, % − 0.018 0.983 (0.932–1.036) 0.516
Model 3    
 Hs-CRP, mg/L 0.028 1.028 (1.016–1.04) P < 0.001
 CHADS2 score 0.338 1.403 (1.025–1.92) 0.035
Model 4    
 Hs-CRP, mg/L 0.028 1.028 (1.015–1.041) P < 0.001
 CHA2DS2-VASc score 0.425 1.529 (1.173–1.994) 0.002
  1. Variables included in model 1 are age, hs-CRP and BNP. Variables included in model 2 are age, hs-CRP, LAD and LVEF. Variables included in model 3 are hs-CRP and the CHADS2 score. Variables included in model 4 are hs-CRP and the CHA2DS2-VASc score
  2. NOAF, new-onset atrial fibrillation; Hs-CRP, high sensitive c-reactive protein; BNP, B-type natriuretic peptide; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LAD, left atrium diameter; LVEF, left ventricular ejection fraction;